PARIS — AI is advancing our understanding of the complexities of age-related macular degeneration, according to a presenter.
At the Euretina congress Ursula Schmidt-Erfurth, MD, said AI and AI-based tools are providing guidance on disease management, supporting research and drug development and creating opportunities for community-based eye screening.
Schmidt-Erfurth, who was honored with the Euretina Lecture, reviewed the many applications of AI-based OCT analysis.
In neovascular AMD, AI algorithms can quantify and monitor the changes in fluid volume in three compartments: intraretinal fluid